| INTRODUC TI ON
As the second most common malignant tumor in the world, 1 cervical cancer is known to be a serious threat to women's health. In 2012, there were over 500 thousand new cases of cervical cancer diagnosed worldwide and over 26 thousand related deaths. 2 Based on DNA sequencing data analysis, more than 200 types of human papillomaviruses (HPVs) have been confirmed, of which 85 genotypes of HPVs are well characterized, and 120 isolates need to be validated as new genotypes. 3, 4 According to a report of the International HPV Reference Center, the HPV family comprises 202 different genotypes. 5 HPVs preferentially infect the mucosa of the genitals, upper-respiratory tract, and the skin, 6 and they are recognized as important pathogenic factors of cervical cancer and precancerous lesions. 73. 5 The HR-HPVs are the causes of approximately 5% of all cancers in humans and one-third of all virus-induced tumors. 6 In contrast with HR-HPV infections, LR-HPV infections remain unknown, and they are classified as low risk because they have little or no association with cancer. 9 HPV infections, especially persistent infections from HR-HPVs, can lead to cervical intraepithelial neoplasia and cervical cancer 10, 11 by remaining in the cervix long enough to cause abnormalities.
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As the primary etiologic agents of cervical cancer are known to be HPVs, this type of cancer and other HPV-associated malignancies might be prevented or treated by HPV vaccines. 15 Previous epidemiological studies have shown that the prevalence of HPV infection and genotype distribution differs among regions, 16, 17 and a molecular epidemiological study of HPVs could provide useful data to support reasonable local vaccination strategies. 18 There is a great need for more local data on HPV infections and genotype distribution in women of different populations, which can then be used to evaluate the efficacy of the HPV vaccine in different populations 19 and contribute to the development of cervical cancer screening. 20 China covers a large territory and has many ethnic groups, and the distribution characteristics of HPVs in different regions are not the same. Wuhan is a city in central
China with a 2014 population of 10.34 million, and it is one of the largest cities in China. As China's population is unvaccinated and represents 19% of the total world population, 21 a large sample size epidemiological study on HPV infection and subtype distribution in this region should be performed to guide the prevention and treatment of cervical cancer. In this study, a total of 13 775
patients from our outpatient department were identified for a molecular epidemiological survey, which may provide evidence for further etiological diagnosis, treatment and prevention in this region.
| MATERIAL S AND ME THODS

| Study population
The participants in this study consisted of 13 775 women who received an annual routine gynecological examination from January 2014 to December 2015 at an outpatient clinic of the Department or had a history of total or partial uterine or cervical resection.
Retrospective observation showed that all the participants were between 16-83 years old, and they were divided into 8 age groups, each covering a 5-year range.
| Ethical standards
The clinical protocol of this study was approved by the Clinical 
| Specimen collection and management
On the day of sample collection, the participants could not be menstruating, be receiving pelvic radiotherapy, have had vaginal administration or irrigation in the previous 3 days, or have been sexually active within the prior 24 hours. After the cervix uteri were fully exposed with the aid of a vaginal speculum, a specially designed cervical brush (known as a cytobrush) gently scoured the cervix uteri through a series of 5 clockwise rotations to obtain the cervical secretions and cells needed for further testing. The samples were placed in a cell preservation solution and stored at −80°C until HPV DNA extraction and genotyping could be performed. The HPV genotype testing of the samples was completed within a week.
| HPV DNA extraction, PCR amplification and genotyping
The entire detection process included HPV DNA extraction, polymerase chain reaction (PCR) amplification and HPV genotyping.
Genomic DNA was first extracted from the collected samples using a DNA extraction kit (Chaozhou Hybribio Biochemical Co., Ltd., Chaozhou, China) according to the manufacturer's instructions.
All the DNA samples were amplified using the Real-Time PCR system ABI 7500 (Applied Biosystems, USA) using a PCR reagent kit (Chaozhou Hybribio Biochemical Co., Ltd. 
| Statistical analysis
All the data were analyzed using SPSS 17.0 software package (GraphPad Software, San Diego, CA, USA). Measurement data such as participant age were presented as the mean ± SD. The chi-square test was used to compare HPV prevalence across groups. Data were considered to be statistically significant when the P value was <.05.
| RE SULTS
| Overall prevalence of HPV infections
A total of 13 775 samples from consecutively selected study participants who underwent routine molecular biological examination were analyzed by HPV genotyping. The mean age of the study population was 32.98 ± 8.58 years, with an age range from 16 to 83 years. Figure 2B ).
A review of the constituent ratio of the entire group of HPVpositive patients showed that HPV 52 was the most common genotype, followed by HR-HPVs 16, 58, 81, 39, and 51, with HPV 81 ranked first among LR-HPVs, followed by HPVs 6, 11, and 44 ( Figure 2A ,B).
| Age-specific distribution of HPV infection
The HPV-infected patients, with an average age of (Table 1) Table 1 and indicate positive infection rates of HR-HPVs and LR-HPVs, ranging from 12.80% (in age group 31-35 years) to 17.84%, (in age group ≤25 years), and from 2.89% (in age group 31-35 years) to 5.35% (in age group ≥56 years). Among all 8 age groups, the infection rates of the ≤25 years group were the highest (P < .05).
The infection rates of HR-HPVs were significantly higher than those of LR-HPVs across the different age groups (in each case, P < .05).
An examination of the distribution trend of HPV infections
shows that after one infection peak at the age of ≤25 years, the trend is downward from >25 years to 35 years, followed by an upward trend from age 31 to 50 years ( Figure 3 ). For the period of 46-56 years, this upward trend in HR-HPV infections persisted, but the total infection rate and the rate of LR-HPV infections begin to decline. After the age of 56 years, the infection rate of total HPVs and HR-HPVs declines, while the rate of LR-HPVs appears to rise.
The rates of HR-HPV, LR-HPV, and overall HPV infections in different age groups indicates that once women reach middle age, there is a downward trend in HPV infection, while the infection rates for LR-HPVs remained fairly stable across the age groups observed 
| Distribution characteristics of single and multiple infections
The analysis of single and multiple HPV infections across the entire sample of 13 775 subjects (2436 HPV-positive cases, infection rate of 17.68%) showed that the infection rates of single and multiple (Table 2 ). In actuality, only one case with 7 genotypes of HPV infection was found in this study.
Among HR-HPV infections, the infection rates of single HPVs 52, 16, 39, and 18 were significantly higher than those of multiple genotypes of HR-HPV infections (in each case, P < .05), and among infection rates of LR-HPVs, only the multiple infection rate of HPV 11 was significantly higher than its single infection rate (P < .05; Figure 5 ).
| Seasonal distribution characteristics
All the participants in this HPV genotyping study were divided by season into spring, summer, autumn, and winter groups of 3292, 3076, 4129, and 3278 women, respectively. The HPV-positive numbers of the 4 seasonal groups were 507, 559, 740, and 630, with positive detection rates of 15.40%, 18.17%, 17.92%, and 19.22%, respectively (Table 3 ). Statistical analysis suggests that HPV detection rates in summer and winter are significantly higher than those in spring and autumn (P < .05). Figure 6 shows the ranking of the most common HPV genotypes, including HR-HPVs and LR-HPVs, found in women from the different seasonal groups, and these HPV distribution characteristics are clearly similar to those observed year-round. 
| D ISCUSS I ON
A number of previous studies have confirmed that HPV infection is a causal and necessary factor for cervical cancer, 3, 27, 28 and persistent HPV infections in particular are primarily associated with the development of this type of cancer in women. 5 A positive HPV DNA test result in women indicates a risk of developing cervical cancer. 22 This type of cancer is considered the second most common malignancy in women worldwide and represents 9.8% of all cancer in women. 28 To prevent the development of HPV infections in women, HPV vaccines 33 (Western China). In sum, these regional differences may be due to variation in the ranking of the prevalence estimates of these HPV genotypes by region.
TA B L E 2 Comparison of the constituent ratios of single and multiple infections of positive HPV infections
F I G U R E 5 Distribution of single and multiple infections of HR-HPV/HR-HPV and LR-HPV/LR-HPV genotypes
TA B L E 3 Comparison of HPVs infection in different season of 1 year
In the present study, the participants ranged in age from 16
to 83 years, with the average age being 32.98 ± 8.58. In addition, women infected with HPV, especially HR-HPV, were as young as 16 years old, which may indicate that sexual activity in women starts early today. As there is a close relationship between HPV infection and sexual activity, 28, 34 and previous analysis has indicated that HPV infection may be acquired relatively quickly after the first sexual intercourse, it is extremely important that females at an early age, even before the start of sexual activity, participate in a school-based vaccination program. 34 In addition, the results showed that HR-HPV infection can occur in women ranging in age from 16 to 83 years, which indicated that HPV may infect women of all ages.
As this is an epidemiological investigation, composition ratio This exception may be due to less frequent sexual activity in Asian women, especially older women.
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Although cervical cancer is a typical aging disease with a starting age from 15 years worldwide, the incidence of this disease was ob- 
| CON CLUS IONS
In summary, this study showed a high prevalence of HPV genotypes 52, 16, 58, 39, 51, and 53 in HR-HPVs, and 81, 6, 11, 44, and 43 in LR-HPVs in Wuhan, China. There were 2 prevalence peaks of HPV infection among women aged ≤25 and 46-55 years. Beyond the age range of 51-55 years, both total and HR-HPV infection rates decline, while the low infection rate of LR-HPV remains fairly stable.
Rates of single infections were significantly higher than rates of coinfection in almost all single or multiple genotype infections. Over the course of a year, the infection detection rates in the summer and winter were greater than those in the spring and autumn. The data from this study may serve as a baseline for further monitoring and can be used to emphasize the complexity of HPV genotype distribution and the importance of local HPV surveys for vaccination strategies and the national cervical cancer prevention program.
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